Open AccessA multicentre, prospective, randomised, double-blind study to measure the treatment effectiveness of abobotulinum A (AboBTXA) among women with refractory interstitial cystitis/bladder pain syndrome
Author(s) -
Jane Manning,
Peter Dwyer,
Anna Rosamilia,
Kim Colyvas,
Christine Murray,
Elizabeth Fitzgerald
Publication year - 2013
Publication title -
international urogynecology journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.933
H-Index - 92
eISSN - 1433-3023
pISSN - 0937-3462
DOI - 10.1007/s00192-013-2267-8
Subject(s) - medicine , interstitial cystitis , refractory (planetary science) , bladder pain syndrome , double blind , urinary system , urology , surgery , placebo , physics , alternative medicine , pathology , astrobiology
To determine if abobotulinumtoxin A (AboBTXA) is an effective treatment for interstitial cystitis/bladder pain syndrome (IC/BPS).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom